Finance News – Linerixibat
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Ceo
Tariffs
Investors
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Bse
Xrp
Etf
Stablecoin
Eth
Investment
Blockchain
Ipo
Index
Solana
Sec
Earnings
Trade
Inflation
Revenue
Interest Rates
Sensex
Token
Coinbase
Wall Street
Treasury
Nasdaq
Nse
Federal Reserve
China
Bse Sensex
Traders
Nifty
Sp 500
Gold
Profit
Investor
Tesla
Company
Economy
Retail Activity
Data Availability
Rose
Tourism Websites
Kgaa
Tariff Dispute
Tether Ceo
Hamilton Court Group
Chemist Warehouse
Kbw
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jul 17, 2025
GSKâs Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associate...
The introduction of GSK’s new therapy for itching related to primary biliary cholangitis could potentially generate significant revenue by meeting patient needs not fully addressed...
Read Full Article →